Otsuka Holdings Co., Ltd. (OTSKY)

Market Cap	26.59B
Revenue (ttm)	15.98B
Net Income (ttm)	2.34B
Shares Out	n/a
EPS (ttm)	4.34
PE Ratio	11.35
Forward PE	n/a
Dividend	0.80 (3.31%)
Ex-Dividend Date	Jun 27, 2025

Volume	2,949
Average Volume	53,673
Open	24.76
Previous Close	23.70
Day's Range	24.68 - 25.01
52-Week Range	21.64 - 32.41
Beta	0.06
RSI	62.51
Earnings Date	Jul 31, 2025

About Splunk

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKY

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.